Harrow Health Forms Stowe Pharmaceuticals Subsidiary to Develop Broad Spectrum Anti-Microbial Ophthalmic and Otic Therapeutics

    NEXT STORY
    Athenex Provides an Update Regarding the Vasopressin Case
    PREV STORY
    Amicus Therapeutics Receives Marketing Authorization for Galafold® (migalastat) for Fabry Disease in Argentina
    Subscribe to PM360
    Print Subscription
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    BioAegis Therapeutics and the T.H. Chan-Harvard School of Public Health Demonstrate “Delayed Therapy with Plasma Gelsolin Improves Survival in Murine Pneumococcal Pneumonia” at ID Week

    MORRISTOWN, N.J. and BOSTON, Oct. 18, 2017 (GLOBE NEWSWIRE) -- (BIOAEGIS THERAPEUTICS)BioAegis Therapeutics Inc., ...

    author_avatar
    NASDAQ Market News

    Chi-Med Files Application to List in Hong Kong and Announces Proposed Global Offering

    author_avatar
    NASDAQ Market News

    Apricus Biosciences Announces Year-End 2015 Update and 2016 Growth Strategy

    SAN DIEGO, Jan. 06, 2016 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical ...

    author_avatar
    NASDAQ Market News